- Report
- January 2025
- 240 Pages
Global
From €4232EUR$4,799USD£3,651GBP
- Report
- May 2025
- 182 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- May 2025
- 189 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 264 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,765GBP
- Report
- March 2024
- 110 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3412EUR$3,869USD£2,943GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3412EUR$3,869USD£2,943GBP
- Report
- June 2024
- 140 Pages
Europe
From €3412EUR$3,869USD£2,943GBP
- Report
- September 2022
- 30 Pages
Global
From €2425EUR$2,750USD£2,092GBP
- Report
- October 2023
- 140 Pages
Global
From €3140EUR$3,560USD£2,708GBP
€3925EUR$4,450USD£3,385GBP
- Report
- May 2024
- 200 Pages
Global
From €3660EUR$4,150USD£3,157GBP
- Report
- April 2023
- 220 Pages
Global
From €3175EUR$3,600USD£2,738GBP
- Report
- February 2024
- 245 Pages
Global
€4405EUR$4,995USD£3,800GBP
- Report
- September 2022
- 342 Pages
Global
From €8378EUR$9,500USD£7,227GBP
- Report
- November 2024
- 89 Pages
Global
From €3500EUR$4,251USD£3,125GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$4,251USD£3,125GBP
- Report
- July 2025
- 50 Pages
Global
From €2337EUR$2,650USD£2,016GBP
- Report
- July 2025
- 50 Pages
Global
From €2337EUR$2,650USD£2,016GBP

The Phentermine market is a subset of the Anti-Obesity Drugs market, which is composed of pharmaceuticals used to treat obesity. Phentermine is a sympathomimetic amine, which is an appetite suppressant that works by stimulating the hypothalamus gland and affecting certain neurotransmitters to decrease appetite. It is typically prescribed for short-term use, as it can be habit-forming and has potential for abuse. Common side effects include dry mouth, insomnia, and increased heart rate.
The Anti-Obesity Drugs market is composed of a variety of products, including Phentermine, Orlistat, Lorcaserin, and Bupropion. These products are used to treat obesity, either alone or in combination with lifestyle changes such as diet and exercise.
Some companies in the Phentermine market include KVK Tech, Inc., Actavis, Inc., Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more